Article | June 21, 2021

Why Companies Are Choosing To Manufacture Biopharmaceuticals In Australia

Source: Luina Bio
iStock-1179679055-brisbane-australia

World-class researchers and state-of-the-art facilities, a streamlined regulatory framework, and generous tax incentives have made Australia a prime location for the biotech industry.

Over the past decade, Australia has become a global leader in life science research and biologics manufacturing. Generous tax incentives and government funding are further strengthening its position as a prime location for biotech companies.

Placed 17th in 2010, Australia has jumped to fifth (out of 54 countries) in global biotechnology1, outperforming countries like the United Kingdom, Germany, and Canada.

Australia is home to more than 400 locally-owned biotechnology and 500 MedTech companies, and with around 50 multinationals operating subsidiaries in Australia, including GSK, Merck, Pfizer, Bristol-Myers Squibb, and Novartis, the Australian life sciences sector is valued at over AU$100 billion.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: